Amiodarone is a commonly used antiarrhythmic drug and can cause liver steatosis. We investigated the role of endoplasmic reticulum (ER) stress/unfolded protein response in the pathogenesis of amiodarone-induced steatosis. Amiodarone-induced liver injury was obtained by 1 intraperitoneal injection to wild-type (WT) or C/EBP homologous protein knock-out mice (Ddit3 À/À ). Amiodarone directly reduced intracellular ATP and Ca 2þ in hepatocytes in vitro, inducing ER stress and lipid accumulation. In vivo, amiodarone-driven liver damage and lipid accumulation was accompanied by activation of ER stress/unfolded protein response, as demonstrated by up-regulation of genes encoding key ER stress mediators and by phosphorylation of eIF2a. In contrast to WT mice, Ddit3 À/À mice were protected from amiodarone-induced ER stress and lipid accumulation. Importantly, amiodarone-induced lipid accumulation was not mediated by de novo hepatic lipogenesis, increased adipose tissue lipolysis or increased hepatic uptake of triglycerides or free fatty acids. Rather, amiodarone strongly increased hepatic mRNA expression of lipid droplet proteins, particularly Cidea and Cidec, in WT, but less so in Ddit3 À/À mice, suggesting a link between ER stress and increased triglyceride storage.
Drug-induced lipotoxicity also known as drug/chemotherapy associated steatohepatitis is increasingly recognized as a form of drug-induced liver injury, accounting for 2% of nonalcoholic fatty liver disease and steatohepatitis cases (Farrell, 2002; Grieco et al., 2005) .
Amiodarone chlorhydrate is a di-iodinated benzofuran derivative, class III antiarrhythmic drug for the treatment and prevention of both ventricular and atrial arrhythmias. Amiodarone is a potent antiarrhythmic drug, but its use is associated with various adverse effects, such as thyroid dysfunction, corneal microdeposits, photosensitivity, skin discoloration, peripheral neuropathy, and pulmonary toxicity. Hepatic toxicity associated with amiodarone therapy is common and occurs following both intravenous infusion (acute toxicity) and following long-term oral therapy (chronic toxicity). Amiodarone causes severe acute hepatitis with significant rise in transaminases and occasional reports of fulminant hepatic failure and even death (Lewis et al., 1989; Vassallo and Trohman, 2007) . Chronic toxicity of amiodarone usually presents with mild asymptomatic elevations of aminotransferases (Fromenty et al., 1990; Vitins et al., 2014) . Amiodarone-induced steatosis, both macrovesicular and microvesicular, is commonly observed with histological features of steatohepatitis such as hepatocytes ballooning, Mallory bodies, and fibrosis (Lewis et al., 1989; Vassallo and Trohman, 2007) . Although hepatic injury is usually reversible upon cessation of treatment, it may take weeks or even months for liver enzymes to normalize. Remarkably, unlike most other cases of druginduced liver injury, liver damage from amiodarone may progress despite discontinuation of the drug; explained by its long half-life and its substantial volume of distribution (Lewis et al., 1989; Vassallo and Trohman, 2007) .
The mechanism of amiodarone-induced steatosis is poorly understood. Amiodarone and its metabolites have been shown to inhibit electron transport and uncouple oxidative phosphorylation in mitochondria, decrease mitochondrial b-oxidation and increase production of reactive oxygen species. Several genes associated with lipid metabolism were found to be regulated by amiodarone. PPARa targets were enriched among amiodaronedependent genes, suggesting a constant competition between increased lipid synthesis and the counter response of increased b-oxidation Furthermore, genes associated with increased lipogenesis were induced (Antherieu et al., 2011; Lewis et al., 1989; Szalowska et al., 2014; Vassallo and Trohman, 2007) . The molecular mechanisms that regulate these phenotypes are unknown.
The endoplasmic reticulum (ER) is the cellular site for protein folding. ER stress occurs when folding demand exceeds folding capacity and induces homeostatic signaling reactions, termed the unfolded protein response (UPR) (Ron and Walter, 2007) . UPR in mammalian cells is mainly transduced by 3 sensors, inositolrequiring enzyme 1 (IRE1), pancreatic ER kinase (PKR)-like ER kinase (PERK), and activating transcription factor 6 (ATF6). IRE1 and PERK are activated by auto-phosphorylation, whereas ATF6 is activated by intramembrane cleavage. Activated IRE1 splices the mRNA of X-Box Binding Protein 1(XBP1), yielding the potent transcription factor sXBP1. Activated PERK phosphorylates eIF2a, inducing selective translation of ATF4 and activation of ATF3 and CHOP (Ron and Walter, 2007) .
Activation of the UPR leads initially to attenuation of protein synthesis and protein translocation into the ER, preventing further misfolding, followed by an increase in ER folding capacity (Hotamisligil, 2010) . If the stress is not relieved in a timely fashion, cell death is triggered (Fu et al., 2012) . Whereas acute ER stress leads to apoptosis, chronic sublethal ER stress, causes cellular adaptation and resistance to apoptosis. Thus, depending on its intensity and duration, ER stress could profoundly affect cellular homeostasis.
ER stress/UPR activation has been reported in murine models of hepatic steatosis and contributes to fat accumulation and lipotoxicity (Ozcan et al., 2006; Puri et al., 2008; Rutkowski et al., 2008) . Mice defective for ER stress/UPR genes developed marked microvesicular steatosis when treated with ER stress inducers (Rutkowski et al., 2008) . Only limited reports have investigated the role of ER stress in drug-induced steatohepatitis (Sharma et al., 2011; Wang et al., 2013) .
In the current study, we explored the role of ER stress/UPR in regulating amiodarone-induced steatosis. ER stress/UPR was rapidly activated both in vivo and in vitro following amiodarone administration. Reducing ER stress, either by chemical chaperones or in genetically modified mice with disturbed ER stress response resulted in a marked improvement in amiodaroneinduced steatosis. We found increased hepatic lipid storage secondary to decrease ATP generation possibly due to the known impaired b-oxidation caused by amiodarone and reduced lipolysis. The results highlight a novel mechanism of amiodarone hepatic lipotoxicity and point to a possible strategy to treat amiodarone-induced liver injury. Western-blot analysis. Western blots of liver extracts were performed as previously described (Uzi et al., 2013) . The antibodies used were: Phospho and total eIF2a, CHOP, IRE1a, pHSL (Cell Signaling, Danvers, MA), ATF6, pIRE1, Bip, Plin2, CIDEC (Abcam, Cambridge, UK), XBP1 (Santa Cruz Biotechnology, Paso Robles, CA).
MATERIALS AND METHODS
Immunohistochemical and immunofluorescence staining. Paraffin liver sections were deparaffinized and stained with the indicated antibodies overnight at 4 C. Secondary antibody exposure was performed using the Mach 3 tool kit (Biocare Medical, Pacheco, CA) following the manufacturers' instructions and developed using DAB (Vector Labs, Burlingame, CA). For immunofluorescent staining, frozen sections or cells grown on slides were fixed with 4% formaldehyde and visualized with a Zeiss LSM-TPMT confocal microscope.
Statistical analysis. Results are presented as averages 6 SE of at least 3 independent experiments. Statistical significance was assessed using a two-tailed Student's t-test with P value <.05 considered significant.
RESULTS

Amiodarone Induces ER Stress, Actives the UPR and Induces Lipid Accumulation in Immortalized Hepatocytes In Vitro
Amiodarone has been reported to act as a calcium channel blocker, reducing intracellular Ca 2þ (Lubic et al., 1994) . In addition, amiodarone causes mitochondrial damage, uncoupling oxidative phosphorylation and impairing b-oxidation (Berson et al., 1998; Fromenty et al., 1990) . One of the main mechanisms of ER stress is ER Ca 2þ depletion, regulated by the ATP-dependent pump, sarco/ER Ca 2þ -ATPase (SERCA), and in fact thapsigargin induces ER stress via irreversible SERCA inhibition (Fu et al., 2012) . We hypothesized that amiodarone may cause ER stress via impaired mitochondrial respiration and energy production leading to reduced cellular ATP levels and via reduced ER Ca 2þ and inhibition of SERCA activity. We therefore investigated whether amiodarone affected cellular ATP levels. As shown in Figure 1A , treatment with amiodarone for 30 min, 1 h or 2 h reduced ATP levels by approximately 50%. In addition, we found that amiodarone treatment rapidly and significantly We determined whether amiodarone induces ER stress and activates the UPR in immortalized hepatocytes, prepared as previously described (Uzi et al., 2013) . Spliced XBP1 (sXBP1), the hallmark of UPR activation, and its direct target Erdj4 were significantly up-regulated 2-4 h following amiodarone treatment, indicating a rapid activation of the IRE1-XBP1 arm of the UPR (Figs. 1C and D) . The PERK-eIF2a arm of the UPR activates the transcription and translation of ATF4, which is responsible for the up-regulation of Atf3 and Chop mRNA. ATF3 can further promote CHOP transcription forming a positive feedback loop (Lee et al., 2003) . We observed a marked up-regulation in Atf4 and Chop mRNA levels, reaching a peak 4 h following drug exposure ( Figure 1C ).
We next analyzed the effect of amiodarone on expression of proteins involved in the UPR pathway. Both ATF6 and CHOP were increased within 4 h of amiodarone treatment. In addition, amiodarone induced the phosphorylation of eIF2a and IRE1a, but there was no significant change in BIP levels ( Figure 1E and Supplementary Figure 1) . These data indicate a canonical UPR activation by amiodarone. CHOP, sXBP1 and the N-terminal portion of ATF6 accumulate in the nucleus following UPR induction (Lange et al., 2008; Marciniak et al., 2004) . We examined whether these proteins undergo the expected nuclear translocation and observed that ATF6, CHOP, and XBP1 were observed primarily in the nucleus, suggesting their active engagement in transcription. BIP, an ER resident protein, formed peri-nuclear puncta, typical to ER stress conditions ( Figure 1F ). These results show that within 2-6 h amiodarone induces a robust UPR that involves all 3 canonical arms and affects the physiology of the ER.
Previous studies have shown that prolonged exposure to amiodarone in cell culture (24 h and 14 days) markedly affected genes associated with lipid metabolism (Antherieu et al., 2011) . To explore whether lipid accumulation coincides with the observed UPR, immortalized hepatocytes were stained for lipid droplets 4 h after exposure to amiodarone and observed a 75.8 6 1.2-fold increase in fat content ( Figure 1G ).
Amiodarone Induces ER Stress, Actives the UPR and Induces Lipid Accumulation In Vivo In order to determine whether amiodarone also induces liver UPR in vivo, WT mice were injected i.p. with amiodarone (250 mg kg À1 body weight) and sacrificed 24 h later. Amiodarone-induced mRNA levels of ER stress/UPR genes (sXbp1, Erdj4, P58 ipk , Atf4, and Chop) (Figure 2A ) and protein expression of ATF6, CHOP and BIP and peIF2a ( Figure 2B ). Immunohistochemistry analysis for ATF6, CHOP, BIP, and phospho-eIF2a showed an increase in zone 3 of the liver following amiodarone administration (Figure 2C ), the hepatic area particularly vulnerable to drug-induced injury (Gebhardt et al., 1988; Ghafoory et al., 2013) . Lastly, amiodarone treatment resulted in increased lipid accumulation, as exemplified by Oil Red O staining ( Figure 2D ). Our results indicate that amiodarone causes liver injury and activates the ER stress/UPR pathway in vivo.
CHOP Promotes Amiodarone-Induced Steatosis In Vivo
We previously showed that Ddit3 À/À mice are partially protected from acetaminophen-induced liver damage, which also involves the development of ER stress conditions (Uzi et al., 2013) . CHOP is not only an apoptosis inducer, but also a metabolic regulator via its binding of other members of the C/EBP family members and can act as a dominant-negative transcription factor (Chikka et al., 2013; Rutkowski et al., 2008) . To examine whether ER stress and CHOP specifically play a role in amiodarone-induced steatosis, Ddit3 À/À mice were injected i.p.
with amiodarone and compared with control mice with respect to UPR induction and development of liver damage and steatosis. Indeed, mRNA expression of ER stress markers Xbp1 and Erdj4 were markedly decreased in Ddit3 À/À mice compared with their WT counterparts, indicating reduced UPR ( Figure 3A) . Although amiodarone significantly induced ALT and AST plasma levels in WT mice, indicative of liver damage, these enzymes were not induced in the Ddit3 À/À mice ( Figure 3B ).
If ER stress becomes a chronic condition and cannot be resolved by activation of the UPR, it can lead to apoptosis (Ron and Walter, 2007) . It has previously been shown that prolonged CHOP expression leads to caspase 12-induced apoptosis, therefore, we assessed caspase 12 activity following amiodarone treatment of WT and Ddit3 À/À mice. We found that amiodarone induced only a mild increased in caspase 12 activity (10% increase), whereas amiodarone treatment in Ddit3 À/À mice did not increase caspase 12 activity, but rather reduced it (Supplementary Figs. 2A and B) . TUNEL assay also showed that amiodarone-induced hepatocyte apoptosis in WT mice, but not in Ddit3 À/À mice, suggesting that this apoptosis is caspase 12 dependent (Supplementary Figure 2C) . We have seen that in vitro induction of ER stress by amiodarone is accompanied by lipid accumulation ( Figure 1G ). Amiodarone increased hepatic TG levels and Oil Red O staining in WT mice, but not in Ddit3 À/À mice (Figs. 3C and D) . These data indicate that CHOP is required for the development of liver damage, liver steatosis, and ER stress by amiodarone.
Amiodarone-Induced Lipid Accumulation Is Not Due to De Novo Hepatic Lipogenesis or to Increased Uptake of TG or FFA
In order to determine whether amiodarone-induced lipid accumulation in WT mice was due to increased de novo lipogenesis, we analyzed mRNA levels for genes involved in lipogenesis, as well as genes involved in b-oxidation. Amiodarone significantly decreased expression of transcription factors Sterol regulatory element-binding protein 1 (Srebp1), and carbohydrate response element binding protein (Chrebp) and of diacylglycerol O-acyltransferase 2 (Dgat2) in WT mice ( Figure 4A ). There was a markedly increased mRNA expression of carnitine palmitoyltransferase (Cpt1), an enzyme involved in b-oxidation ( Figure  4A ). Basal expression of all lipogenesis genes was increased in Ddit3 À/À mice compared with their expression in WT mice, but amiodarone did not further affect their expression ( Figure 4A ). These data suggest that amiodarone-induced ER stress does not cause lipid accumulation via promotion of de novo lipogenesis in WT mice. Another possibility for amiodarone-induced steatosis is that the hepatic lipids originate from adipose tissue by ER stressinduced lipolysis, as previously shown (Diao et al., 2015) .
We examined serum levels of free fatty acids (FFA) in WT and Ddit3 À/À mice and detected no change induced by amiodarone in either murine strain ( Figure 4B ). In addition, amiodarone reduced serum TG levels in WT, but not in Ddit3 À/À mice ( Figure   4C ), suggesting both reduced de novo lipogenesis and reduced TG secretion. We next assessed mRNA expression of genes involved in either TG uptake (Lpl, Vldlr) or FFA uptake (Fabp1). Of note, tunicamycin-induced ER stress has been shown to induce lipid accumulation via increased VLDLR and increased hepatic TG uptake (Jo et al., 2013) . We detected significantly reduced Vldlr and Fabp1 in amiodarone-treated WT mice ( Figure 4D ). Basal expression Fabp1, Lpl, and Vldlr was higher in the Ddit3 À/À mice compared with WT mice, but amiodarone did not further increase that basal expression ( Figure 4D ). Importantly, FABP1 is a FFA chaperone, regulating both uptake and secretion of FFA (Wang et al., 2013) , therefore reduced levels could indicate reduced hepatic FFA secretion.
Amiodarone-Induced Lipid Accumulation Is Correlated With
Increased TG Storage and Reduced Hepatic Lipolysis Next, we examined mRNA expression of lipid droplet proteins Cidea, Cidec, and Perilipin 2 (Plin2) in amiodarone-treated WT and Ddit3 À/À mice. We detected a dramatic increase in gene expression of Cidec and Cidea (25-to 35-fold increase) in WT mice, an increase which was strongly attenuated in Ddit3 À/À mice (only 3-to 5-fold increase) ( Figure 5A ). Moreover, we found that protein levels for CIDEC were increased in amiodarone-treated WT, but not in amiodarone-treated Ddit3 À/À mice ( Figure 5B ).
Amiodarone did not affect mRNA or protein levels of PLIN2 (Figs. 5A and B) . The increased Cpt1 mRNA levels in amiodarone-treated WT mice suggest an attempted increase of b-oxidation. However, amiodarone has been shown to cause mitochondrial damage (Fromenty et al., 1990) , so b-oxidation may be impaired or inefficient. TG stored in the hepatic lipid droplets can undergo lipolysis and be used for b-oxidation in the mitochondria. We determined lipolysis in WT and Ddit3 À/À mice treated with amiodarone, both under basal conditions and following insulin administration. Basal lipolysis was similar in WT and Ddit3 À/À mice treated with amiodarone, as demonstrated by phosphorylation of HSL, an indicator of lipolysis ( Figure 5C ). In contrast, insulin prevented phosphorylation of HSL in WT mice, but not in amiodarone-treated Ddit3 À/À mice ( Figure 5C ). Collectively, these data indicate that amiodaroneinduced ER stress leads to increased lipid storage and steatosis, possibly due to impaired b-oxidation and increase in lipid droplet formation.
In Vivo Treatment With Chemical Chaperones Reduces AmiodaroneInduced ER Stress and Ameliorates Amiodarone-Induced Steatosis The development of ER stress by amiodarone can facilitate amiodarone-induced steatosis or reflect a consequence of mitochondrial damage. In order to assess a causative role of ER stress in amiodarone-induced steatosis, we used 2 compounds that decrease ER stress by 2 different mechanisms. We used Bix, a BIP-inducer (Kudo et al., 2008) , and 4-phenyl butyric acid (4-PBA), which promotes the folding of proteins in the ER (Ozcan et al., 2006) . Both elevate the threshold of unfolded proteins needed to activate the UPR and facilitate protein folding. The prophylactic treatment with Bix markedly decreased liver injury, as demonstrated by reduced levels of ALT and AST ( Figure  6A ). We also assessed the effect of Bix treatment on ER stress gene transcription and protein expression. Spliced Xbp1, Chop, Erdj4, P58 ipk , and Atf4 mRNA expression levels were significantly reduced following the administration of Bix with amiodarone, whereas Bip mRNA, as expected was increased ( Figure 6B ). Treatment with Bix and amiodarone also reduced liver lipid accumulation, as demonstrated by reduced liver TG and reduced staining with Oil Red O (Figs. 6C and D) . In addition, Bix together with amiodarone reduced mRNA expression of lipid doplet proteins Cidea and Cidec ( Figure 6E ). The second compound we used to reduce ER stress in the amiodarone-treated mice, 4-PBA, did not reduce liver damage compared with amiodarone alone ( Figure 7A ). Among ER stress markers, only Erdj4 was reduced by 4-PBA in combination with amiodarone ( Figure 7B ). In contrast, liver TG and lipid accumulation demonstrated by Oil Red staining were reduced by 4-PBA treatment together with amiodarone (Figs. 7C and D) . In addition, 4-PBA and amiodarone significantly reduced the amiodarone-induced increase of Cidec mRNA ( Figure 7E ). These data implicate ER stress as a cause for amiodarone-induced steatosis and suggest this pathway may be amenable for pharmacological intervention.
Our proposed model for the mechanisms controlling hepatic lipid accumulation in an acute amiodarone model of liver damage is summarized in Figure 8 .
DISCUSSION
Amiodarone is a frequently used antiarrhythmic drug known to induce both acute and chronic liver damage hallmarked by steatosis. The mechanisms leading to amiodarone-induced liver injury have not yet been fully elucidated. We investigated the role of ER stress and UPR activation using a murine model of amiodarone treatment. We show that amiodarone administration causes within a few hours a robust ER stress that involves all 3 arms of the UPR, reminiscent of classical ER stressinducing agents, such as thapsigargin. We found that amiodarone reduces both total cellular ATP and intracellular Ca 2þ , suggesting impaired activity of the enzyme responsible for maintaining ER Ca 2þ levels, SERCA (Fu et al., 2012) . The in vitro effect of amiodarone was recapitulated in vivo, again displaying a rapid kinetic pattern that resembles the induction of ER stress by tunicamycin (Tabas and Ron, 2011) . Within 24 h, we observed activation of the UPR manifested in the nuclear accumulation of XBP1 and ATF6 and the hyperphosphorylation of eIF2a, as well as strong accumulation of CHOP, a common target of the IRE1 and PERK pathways. Our study revealed that in vitro and in vivo activation of the UPR coincided with hepatic lipid accumulation, the main manifestation of amiodarone in treated patients. Moreover, these effects were attenuated by chemical chaperones, particularly Bix, and in Ddit3 À/À mice that display reduced ER stress, demonstrating that amiodarone-induced lipid accumulation is ER-stress dependent. Profiling of mRNA gene expression showed that there was no increase in de novo lipogenesis in the amiodarone-treated mice. Previous studies have also shown that ER stress induced by tunicamycin reduced de novo lipogenesis, indicating that ER stress induction of lipid accumulation is probably not mediated by de novo lipogenesis (Rutkowski et al., 2008) . CHOP was identified as a key transcription factor that sits at the crossroads between ER stress, the UPR and metabolic pathways, since as a member of the C/EBP family of transcription factors, it acts as a dominant-negative regulator of other C/EBP members transcriptional metabolic functions. Therefore CHOP plays roles in both ER stress and metabolism and has been shown to inhibit expression of master metabolic transcription factors C/ebpa, Ppara, and Srebpf1 (Chikka et al., 2013; Rutkowski et al., 2008) . The strong protection of Ddit3 À/À mice from amiodarone-induced steatosis underscores this transcription factor as a key element of the early events that lead to the induction of ER stress and lipid accumulation. We observed diminished liver damage in the Ddit3 À/À mice, decreased accumulation of lipids and markedly reduced ER stress. In addition, Ddit3 À/À mice were also protected from amiodaroneinduced apoptosis compared with WT mice, further demonstrating the protective role of CHOP deletion. Of note, the induction of CHOP by amiodarone is not restricted to liver cells, but was recently observed in lung epithelium, a process that led to lung fibrosis within a few weeks (Mahavadi et al., 2014) .
Several models of ER stress and steatosis have implicated up-regulation of the genes encoding lipid droplet proteins. In tunicamycin-induced ER stress, development of microsteatosis and lipid accumulation were accompanied by increased levels of PLIN2 and mediated by CHOP activation (Lee et al., 2012) . In our studies, the strong lipid accumulation induced by amiodarone was accompanied by the increased mRNA expression of lipid droplet proteins Cidea and Cidec, testifying to increased TG storage. In addition, Cidec mRNA expression was strongly attenuated in amiodarone-treated Ddit3 À/À mice and in mice treated with amiodarone and chaperones Bix and 4-PBA. CIDEC is well known for its role in adipose tissue, where it promotes TG storage and inhibits lipolysis both via inhibition of ATGL transcription and via attenuation of ATGL activity (Grahn et al., 2014; Singh et al., 2014) . Recent studies have highlighted a role for CIDEC, which is expressed at low levels in the healthy livers, but strongly induced in alcoholic liver steatosis in both mice and humans (Grahn et al., 2014; Singh et al., 2014; Xu et al., 2015) . Moreover, CIDEC is also a direct target of PPARa (Langhi and Bald an, 2015) , whose activity was shown to be increased by amiodarone (Ernst et al., 2010; McCarthy et al., 2004) .
In conclusion, our data support a model by which amiodarone promotes ER stress, due to impaired b-oxidation, leading to 
